Loading…
Wednesday September 16, 2026 4:30pm - 5:15pm EDT
Pointers to put Competitive Intelligence Teams ahead of the curve
 
  • AI promises to accelerate drug discovery, with better compounds entering the clinic that both reduce the time and money required to develop a drug. Is this already happening? The panel will discuss the challenges of applying AI and machine learning to compound discovery, preclinical testing, identifying the right patients, biomarker development, trial management, and ultimately in silico trials.
  • Discuss what CI Teams should look for to tell hype from reality as companies claim AI based success. Discuss which emerging trends, companies, technologies, and development milestones to pay attention to.  
  • Examine how AI-driven advances could reshape competitive strategy over the next decade.

Moderators
avatar for Ben Weintraub

Ben Weintraub

President, inThought Research

Speakers
avatar for Eddine Maiza

Eddine Maiza

Global Head, Competitive Intelligence, Gilead
avatar for Christopher Roselle, Ph.D.

Christopher Roselle, Ph.D.

Director, Strategy & Operations, Recursion
Christopher Roselle is the Director of Strategy & Operations at Recursion, where he works
across the company’s platform and pipeline on portfolio and operational strategy.
Prior to joining Recursion, Chris worked at Boston Consulting Group, advising
biopharmaceutical companies on... Read More →
Wednesday September 16, 2026 4:30pm - 5:15pm EDT
Junior Ballroom C

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link